ArticleBMC pharmacology & toxicology2018

Preclinical pharmacokinetic evaluation to facilitate repurposing of tyrosine kinase inhibitors nilotinib and imatinib as antiviral agents.

Hari Krishna Ananthula et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.